Pandion Therapeutics Inc Quick Ratio (PAND) starting from the fourth quarter 2020 to fourth quarter , Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Pandion Therapeutics Inc   (NASDAQ: PAND)

Pandion Therapeutics Inc 's Quick Ratio

PAND's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Pandion Therapeutics Inc 's Cash & cash equivalent, this led to improvement in Pandion Therapeutics Inc 's Quick Ratio to 24.83 a new company high.

Within Major Pharmaceutical Preparations industry 65 other companies have achieved higher Quick Ratio than Pandion Therapeutics Inc in fourth quarter 2020. While Quick Ratio total ranking in the fourth quarter 2020 has deteriorated compared to the prior quarter from 175 to 307.

Explain Quick Ratio?
How much Cash & cash equivalents PAND´s has?
What are PAND´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PAND Quick Ratio (Dec 31 2020)
Q4		 (Sep 30 2020)
Q3		 (Jun 30 2020)
Q2		 (Dec 31 2019)
Q2
Q4
Y / Y Current Liabilities Change - - - - -
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ 24.83 19.88 6.31 7.53 -
PAND's Total Ranking # 307 # 175 # 546 # #
Seq. Current Liabilities Change -24.24 % -30.21 % 689.35 % - -
Seq. Cash & cash equivalent Change -5.35 % 119.74 % 562.02 % - -



Quick Ratio fourth quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 66
Healthcare Sector # 104
Overall Market # 307


Quick Ratio Statistics
High Average Low
24.83 14.64 6.31
(Dec 31 2020)   (Jun 30 2020)




Financial Statements
Pandion Therapeutics Inc 's Current Liabilities $ 9 Millions Visit PAND's Balance sheet
Pandion Therapeutics Inc 's Cash & cash equivalent $ 220 Millions Visit PAND's Balance sheet
Source of PAND's Sales Visit PAND's Sales by Geography


Cumulative Pandion Therapeutics Inc 's Quick Ratio

PAND's Quick Ratio for the trailling 12 Months

PAND Quick Ratio

 (Dec 31 2020)
12 Months		 (Sep 30 2020)
12 Months		 (Jun 30 2020)
12 Months		 (Dec 31 2019)
12 Months
12 Months
Y / Y Current Liabilities TTM Growth - - - - -
Y / Y Cash & cash equivalent TTM Growth - - - - -
Quick Ratio TTM 14.56 11.58 6.45 7.53 -
Total Ranking TTM # 3979 # 136 # 136 #
Seq. Current Liabilities TTM Growth 28.98 % 61.94 % 789.35 % - -
Seq. Cash & cash equivalent TTM Growth 62.11 % 190.91 % 662.02 % - -

Quick ratio ranking by company, industry and sector >> Back to PAND Financial Strength Comparisons >> Go to Compare PAND Quick Ratio to its Competitors

On the trailing twelve months basis PAND Cash & cash equivalent decreased by -5.35 % in Q4 2020 year on year, faster than Current Liabilities, this led to increase in in Pandion Therapeutics Inc 's Quick Ratio to 14.56, above PAND average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 451 other companies have achieved higher Quick Ratio than Pandion Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2020 from 136 to 3979.

Explain Quick Ratio?
How much Cash & cash equivalents PAND´s has?
What are PAND´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 452
Healthcare Sector # 864
Within the Market # 3979


trailing twelve months Quick Ratio Statistics
High Average Low
12.09 12.09 12.09
(Dec 31 2020)  




Companies with similar Quick Ratio in the quarter ending Dec 31 2020, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2020 MRQ Cash & cash equivalentDec 31 2020 MRQ Current Liabilities
Genprex Inc   60.62 $ 27.320  Millions$ 0.451  Millions
Seres Therapeutics Inc   56.71 $ 253.616  Millions$ 4.472  Millions
Turning Point Therapeutics Inc.  55.81 $ 1,690.282  Millions$ 30.286  Millions
Hcw Biologics Inc   54.45 $ 8.456  Millions$ 0.155  Millions
Kinnate Biopharma Inc   54.33 $ 396.860  Millions$ 7.304  Millions
Neurosense Therapeutics Ltd  53.77 $ 0.699  Millions$ 0.013  Millions
Psyence Biomedical ltd   52.97 $ 1.446  Millions$ 0.027  Millions
Filana Therapeutics Inc   50.14 $ 93.506  Millions$ 1.865  Millions
Pmv Pharmaceuticals Inc   49.60 $ 361.422  Millions$ 7.287  Millions
Lianbio  47.75 $ 254.350  Millions$ 5.327  Millions
Karuna Therapeutics Inc   47.03 $ 322.330  Millions$ 6.853  Millions
Stoke Therapeutics Inc   46.26 $ 287.308  Millions$ 6.211  Millions
Enliven Therapeutics Inc   44.76 $ 88.222  Millions$ 1.971  Millions
Reata Pharmaceuticals Inc   43.49 $ 818.150  Millions$ 18.813  Millions
Tango Therapeutics Inc   42.36 $ 190.320  Millions$ 4.493  Millions
Aditxt Inc   42.32 $ 10.501  Millions$ 0.248  Millions
Edgewise Therapeutics inc   40.76 $ 129.094  Millions$ 3.167  Millions
Innoviva Inc   40.34 $ 246.487  Millions$ 6.110  Millions
Xbiotech Inc   40.22 $ 237.366  Millions$ 5.902  Millions
Ars Pharmaceuticals Inc   40.08 $ 386.569  Millions$ 9.646  Millions
Eqrx Inc   39.27 $ 490.282  Millions$ 12.484  Millions
Greenwich Lifesciences Inc   37.20 $ 28.660  Millions$ 0.770  Millions
Keros Therapeutics Inc   37.01 $ 265.876  Millions$ 7.184  Millions
Imago Biosciences Inc   36.99 $ 266.641  Millions$ 7.209  Millions
Pasithea Therapeutics Corp   36.92 $ 0.244  Millions$ 0.007  Millions
Nkarta Inc   35.66 $ 314.913  Millions$ 8.831  Millions
Eledon Pharmaceuticals Inc   35.17 $ 114.195  Millions$ 3.247  Millions
Lantern Pharma Inc   34.82 $ 38.458  Millions$ 1.105  Millions
89bio Inc   34.52 $ 280.039  Millions$ 8.113  Millions
Cytokinetics Incorporated  33.86 $ 962.139  Millions$ 28.414  Millions

Date modified: 2026-09-08T15:10:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.